" />

Introduction Hilde Bohets

Hilde Bohets holds a Master in Sciences and a PhD in Medical Sciences. she has more than 20 years’ experience in drug development at Janssen Pharmaceutica (Johnson & Johnson). Hilde was study director, monitor, people leader and drug development leader. As drug development leader, she was responsible for the preclinical plan and budget, negations between the compound development team (CDT) and the line functions in order to get experiments done in time and within the budget. Within the CTD, Hilde collaborated with other team members to get departmental activities aligned. As CDT member she presented and discussed data with different stakeholders and authorities. In addition, she took care of medical writing of regulatory documents and scientific papers.

She is a strong research oriented professional skilled, in Preclinical pharmacokinetics (ADME) and toxicology. She supported development projects in gastrointestinal, infectious disease, oncology and CNS. Her main expertise is oncology. Hilde was early development leader for Edurant and Sirturo, both marketed drugs, and was involved in several due diligence projects, both on in licensing and out licensing. 
Hilde coached several employees (Belgium and Japan) and taught pharmacokinetics on a ad hoc basis at different universities. She was co-promotor of a PhD thesis, was direct supervisor of the pharmacokinetics and in vitro metabolism group (9 employees from bachelor to PhD) and indirect supervisor in my project leader role. 

From a scientific point of view she took the lead in the implementation of several new technics and got IWT funding for a project on immortalization of hepatocytes and on production of metabolites in a bioreactor. Hilde was case by case consulted for IWT or journals as external expert.